| 74775-8 |
Platelets |
NCnc |
PRP |
Pt |
Qn |
Automated count |
|
ACTIVE |
Platelets [#/volume] in Platelet rich plasma by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*3/uL |
|
|
|
|
|
|
HEM/BC |
|
74775-8 |
|
Automated count |
|
|
Both |
|
|
|
0 |
Platelet # PRP Auto |
|
|
|
|
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelet rich plasma; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes |
2.48 |
2.48 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
| 74776-6 |
Human papilloma virus 6 DNA |
LnCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Human papilloma virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
log copies/mL |
|
|
|
|
|
|
MICRO |
|
74776-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPV6 DNA Spec NAA+probe-Log# |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV6; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.69 |
2.48 |
|
|
|
|
|
|
|
{Log_copies}/mL |
|
|
|
0 |
| 74777-4 |
Human papilloma virus 6 DNA |
NCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Human papilloma virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
74777-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPV6 DNA # Spec NAA+probe |
|
|
|
|
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV6; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.69 |
2.48 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 74778-2 |
Human papilloma virus 11 DNA |
LnCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Human papilloma virus 11 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
log copies/mL |
|
|
|
|
|
|
MICRO |
|
74778-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPV11 DNA Spec NAA+probe-Log# |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV11; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.69 |
2.48 |
|
|
|
|
|
|
|
{Log_copies}/mL |
|
|
|
0 |
| 74779-0 |
Human papilloma virus 11 DNA |
NCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Human papilloma virus 11 DNA [#/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
74779-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPV11 DNA # Spec NAA+probe |
|
|
|
|
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV11; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.69 |
2.48 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 7478-1 |
Acer macrophyllum Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Coastal Maple IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7478-1 |
|
|
|
|
Both |
|
|
|
0 |
Coastal Maple IgE Qn |
|
|
|
Y |
|
A macrophylium; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bigleaf Maple; Coastal maple; Immune globulin E; Immunoglobulin E; Oregon Maple; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 74780-8 |
CPT1A gene.c.1436C>T |
PrThr |
Bld.dot |
Pt |
Ord |
Molgen |
|
ACTIVE |
CPT1A gene c.1436C>T [Presence] in DBS by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
74780-8 |
|
Molgen |
|
|
Both |
|
|
|
0 |
CPT1A c.1436C>T DBS Ql |
|
|
|
|
|
Blood; carnitine palmitoyltransferase 1A (liver); CPT1; CPT1A c.1436C>T; CPT1-L; DBS; Dried blood spot; Filter paper; FP; Genetics; Heredity; Heritable; Inherited; L-CPT1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; WB; Whole blood |
2.73 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74781-6 |
Vacuum dust collection contaminant panel |
- |
^Patient |
Pt |
- |
PhenX |
|
ACTIVE |
Vacuum dust collection contaminant panel PhenX |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
74781-6 |
|
PhenX |
|
|
Subset |
|
|
|
0 |
Vac dust collection pnl PhenX |
|
|
|
|
|
Coll; Collect; Collected; Pan; PANEL.PHENX; Panl; Pnl; Point in time; Random; Vac dust collection pnl; Vacuum dust contaminant |
2.48 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 74782-4 |
Arterial pulse intensity |
Force |
Dorsal pedal artery.right |
Pt |
Ord |
Palpation |
|
ACTIVE |
Pulse intensity Dorsal pedal artery - right by palpation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HRTRATE.MOLEC |
|
74782-4 |
|
Palpation |
|
|
Both |
|
|
|
0 |
Pulse intensity Dors pedal a-R Palpation |
|
|
|
|
|
Art; Cardio; Cardiology; Dors pedal a; Dors pedal a-R; Feet; Foot; Heart Disease; Heart Rate; HEART RATE.MOLEC; Mechanical force; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen |
2.48 |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 74783-2 |
Malignant cells |
PrThr |
Body fld |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Malignant cells [Presence] in Body fluid by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
74783-2 |
|
Microscopy.light |
|
|
Observation |
|
|
|
0 |
Malignant cells Fld Ql Micro |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; LM; Malig; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74784-0 |
Influenza virus B lineage RNA |
Prid |
XXX |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Influenza virus B lineage RNA [Identifier] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74784-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUBV lineage RNA Spec NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUBV lineage; FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 74785-7 |
Influenza virus B Victoria lineage RNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Influenza virus B Victoria lineage RNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74785-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUBV Vic RNA Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUBV Vic; FLUBV Victoria; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74786-5 |
Influenza virus B Yamagata lineage RNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Influenza virus B Yamagata lineage RNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74786-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUBV Yam RNA Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUBV Yam; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74787-3 |
Influenza virus B Victoria & Yamagata lineage RNA panel |
- |
XXX |
Pt |
- |
|
|
ACTIVE |
Influenza virus B Victoria and Yamagata lineage RNA panel - Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
74787-3 |
|
|
|
|
Order |
|
|
|
0 |
FLUBV Vic + Yam RNA Pnl Spec |
|
|
|
|
|
FLUB; FLUBV; FLUBV Vic + Yam RNA Pnl; FLUBV Victoria; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified |
2.69 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 74788-1 |
Lactulose challenge panel |
- |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Lactulose challenge (hydrogen breath test) panel - Exhaled gas |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
74788-1 |
|
|
|
|
Order |
|
|
|
0 |
Lactulose HBT Pnl ExG |
|
|
|
|
|
Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Lactulose HBT; Lactulose HBT Pnl; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 74789-9 |
Fructose challenge panel |
- |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Fructose challenge (hydrogen breath test) panel - Exhaled gas |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
74789-9 |
|
|
|
|
Order |
|
|
|
0 |
Fructose HBT Pnl ExG |
|
|
|
|
|
Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Fructose HBT; Fructose HBT Pnl; Gases; Levulose; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Revulose |
2.64 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 7479-9 |
Acer rubrum Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Red Maple IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7479-9 |
|
|
|
|
Both |
|
|
|
0 |
Red Maple IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Red maple; Serum; Soft maple; SR; Swamp maple; t27 |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 74790-7 |
Glucose challenge panel |
- |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Glucose challenge (hydrogen breath test) panel - Exhaled gas |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
74790-7 |
|
|
|
|
Order |
|
|
|
0 |
Glucose HBT Pnl ExG |
|
|
|
|
|
Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Glu; Glu tol; Gluc; Glucose HBT; Glucose HBT Pnl; Glucose tolerance; Glucoseur; GTT; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 74791-5 |
Lactulose challenge |
Imp |
Exhl gas |
Pt |
Nom |
|
|
ACTIVE |
Lactulose challenge (hydrogen breath test) [Interpretation] in Exhaled gas |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHAL |
|
74791-5 |
|
|
|
|
Observation |
|
|
|
0 |
Lactulose HBT ExG-Imp |
|
|
|
|
|
Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lactulose HBT; Nominal; Point in time; Random |
2.54 |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 74792-3 |
Fructose.PO |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Fructose.PO [Mass] in Dose |
|
MIN |
DefinitionDescription |
|
|
g |
|
|
|
|
|
|
CHEM |
|
74792-3 |
|
|
|
|
Both |
|
|
|
0 |
Fructose PO Dose Qn |
|
|
|
|
|
Chemistry; Dose med or substance; Fructose PO; Levulose; Point in time; QNT; Quan; Quant; Quantitative; Random; Revulose |
2.48 |
2.48 |
|
|
|
|
|
|
|
g |
|
|
|
0 |
| 74793-1 |
Thyroid hormone uptake |
NFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyroid hormone uptake (T-uptake) in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
74793-1 |
|
|
|
|
Both |
|
|
|
0 |
T-uptake NFr SerPl |
|
|
|
|
|
Chemistry; Horm; Number fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3 uptake; T3U; T4; Thyroxine Uptake; Triiodothyroinine uptake; T-uptake |
2.73 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 74794-9 |
Thyroid hormone binding ratio |
RelRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyroid hormone binding ratio (THBR) in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
74794-9 |
|
|
|
|
Both |
|
|
|
0 |
THBR SerPl |
|
|
|
|
|
Bind; Chemistry; Horm; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; THBR; T-uptake |
2.48 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 74795-6 |
Total thyroxine binding capacity |
RelRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Total thyroxine binding capacity in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
T-uptake units |
|
|
|
|
|
|
CHEM |
|
74795-6 |
|
|
|
|
Both |
|
|
|
0 |
Total TBC SerPl |
|
|
|
|
|
Bind; Chemistry; Endocrine; Endocrinology; Levothyroxine; Levo-thyroxine; L-thyroxine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Tot; Total T4; Total TBC; Totl; TT4; T-uptake |
2.73 |
2.48 |
|
|
|
|
|
|
|
{T-uptake units} |
|
|
|
0 |
| 748-4 |
Myelocytes |
NCnc |
Bld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Myelocytes [#/volume] in Blood by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
748-4 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Myelocytes # Bld Manual |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; Myel; Myelo; Myelocyte; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
| 7480-7 |
Acer rubrum basophil bound Ab |
ACnc |
Bld |
Pt |
Qn |
LHR |
|
ACTIVE |
Red Maple triggered histamine release [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7480-7 |
|
LHR |
|
|
Both |
|
|
|
0 |
Red Maple BasoBnd Ab Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; Leukocyte histamine reaction; Leukocyte histamine release; Point in time; QNT; Quan; Quant; Quantitative; Random; Red maple; Soft maple; Swamp maple; t27; WB; WBC release; Whole blood |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
